Solomon Moshkevich - 27 Oct 2026 Form 4 Insider Report for Natera, Inc. (NTRA)

Reporting relationship: PRESIDENT, CLINICALDIAGNOSTICS
Issuer ticker: NTRA
Reported as of: 27 Oct 2026
Net transaction value: -$905,468
SEC form: 4
Accepted by SEC: 29 Oct 2026, 21:35:14 UTC
Prior SEC filing: 02 Oct 2026
Source filing: View source filing
Reporting owner signature: /s/ Tami Chen, Attorney-in-Fact

Filing notes and source

Key filing fact

Solomon Moshkevich filed Form 4 for Natera, Inc. (NTRA) on 29 Oct 2026.

Key facts

This page summarizes Solomon Moshkevich's Form 4 filing for Natera, Inc. (NTRA).
2 reported transactions and 0 derivative rows are listed below.
Accepted by SEC: 29 Oct 2026, 21:35.

Change

Previous filing in this sequence was filed on 02 Oct 2026.
Current net transaction value: -$905,468.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0002010019 Primary reporting owner

Moshkevich Solomon

Relationship: PRESIDENT, CLINICALDIAGNOSTICS
Address: C/O NATERA, INC., 13011 MCCALLEN PASS BUILDING A SUITE 100, AUSTIN
Signature: /s/ Tami Chen, Attorney-in-Fact
Signature date: 29 Oct 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

NTRA transaction

Common Stock

Sale

Transaction value: -$410,060
Shares: -1,010
Change %: -0.94%
Price: $406.00
Shares after: 105,904
Date: 27 Oct 2026
Ownership: Direct
Footnotes: F1

NTRA transaction

Common Stock

Sale

Transaction value: -$495,408
Shares: -1,162
Change %: -1.1%
Price: $426.34
Shares after: 104,742
Date: 28 Oct 2026
Ownership: Direct
Footnotes: F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Rule 10b5-1 trading plan

These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.

Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).

Explanation of responses 2 footnotes

Footnote F1

The sale of shares was effected in order to satisfy tax withholding and remittance obligations in connection with the vesting of Restricted Stock Units ("RSUs") and was made pursuant to a written instruction that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act contained in the Reporting Person's Stock Unit Agreement granted on January 26, 2024.

Footnote F2

The sale of shares was effected in order to satisfy tax withholding and remittance obligations in connection with the vesting of RSUs and was made pursuant to a written instruction that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act contained in the Reporting Person's Stock Unit Agreements granted on January 27, 2023.